An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial

Abstract

Objectives We conducted a randomized, controlled trial comparing the efficacy of an Integrated Risk Reduction Intervention (IRRI) to a control condition with the objective of improving mood stability and psychosocial functioning by reducing cardiometabolic risk factors in overweight/obese patients with bipolar I disorder. Methods A total of 122 patients were recruited from our outpatient services and randomly allocated to IRRI (n = 61) or psychiatric care with medical monitoring (n = 61). Individuals allocated to IRRI received psychiatric treatment and assessment, medical monitoring by a nurse, and a healthy lifestyle program from a lifestyle coach. Those allocated to the control condition received psychiatric treatment and assessment and referral, if indicated, for medical problems. A mixed-effects model was used to examine the impact of the interventions on body mass index (BMI). Exploratory moderator analyses were used to characterize those individuals likely to benefit from each treatment approach. Results Analyses were conducted on the IRRI (n = 58) and control (n = 56) participants with ≥ 1 study visit. IRRI was associated with significantly greater rate of decrease in BMI (d = −0.51, 95% confidence interval: −0.91 to −0.14). Three variables (C-reactive protein, total cholesterol, and instability of total sleep time) contributed to a combined moderator of faster decrease in BMI with IRRI treatment. Conclusions Overweight/obese patients with bipolar disorder can make modest improvements in BMI, even when taking medications with known potential for weight gain. Our finding that a combination of three baseline variables provides a profile of patients likely to benefit from IRRI will need to be tested further to evaluate its utility in clinical practice.

The role of day-to-day emotions, sleep, and social interactions in pediatric anxiety treatment

“…That is, we considered a baseline variable to be a moderator if r m > |.15|, and considered it to be a non-specific predictor if r p > |.15| and it was also not identified as a moderator. This cutoff is similar to cutoffs in previously published applications of the combined moderator method (e.g., see Frank et al, 2015; Smagula et al, 2016; Wallace et al, 2013). We also calculated 95% bootstrap simultaneous confidence intervals (SCIs) based on 10,000 replications for the predictor and moderator effect sizes of the characteristics meeting the minimum ES threshold of |.15|.…”

Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: A systematic review

“…After 6 months IRRI was associated with a decrease in BMI. Three physiological measures related to inflammation and neuroendocrinological functioning (C-reactive protein, total cholesterol, instability of total sleep time) led to a faster decrease in BMI (Frank et al, 2014). This study shows that an intervention focusing on developing relevant and individualized therapeutic goals leads to beneficial lifestyle changes positively affecting physiological measures and the BMI.…”

Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission

“…A recent JAMA article titled that ‘resetting the circadian clock might boost metabolic health’ . Health professionals should now define how packages of care for patients with a MetS would include manipulations of sleep homeostasis and circadian rhythms using medications (such as melatonin) or psychosocial approaches .…”